Jessica Banthin
Biographic Data
| ID | 5547611 |
|---|---|
| NAME | Jessica Banthin |
| GIVEN NAMES | Jessica |
| FAMILY NAME | Banthin |
| SIGNATURE | BANTHIN J |
| AFFILIATIONS | Health Policy Center, The Urban Institute, Washington, DC |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Jama Health Forum Peer Reviewers in 2022
Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
In this cross-sectional study of 18 top-selling brand-name drugs, excluding 1 anomaly, Medicaid average net prices declined from 2015 to 2019. Simultaneously, for non-Medicaid payers, net price increased more than previously published marketwide growth rates, raising the importance of restraining drug price growth in non-Medicaid markets. Rigorous and transparent methods to estimate Medicaid discounts are imperative to understand patterns in Medi…
Jama Health Forum Peer Reviewers in 2021
Comparison of Approaches for Estimating Prevalence Costs of Care for Cancer Patients
BACKGROUND: National prevalence costs of medical care can be key inputs in health policy decisions. Cost estimates vary across data sources, patient populations, and methods, however, the objective of this study was to compare 3 approaches for estimating the prevalence costs of colorectal cancer (CRC) care using different data sources, but similar patient populations and methods. METHODS: We identified prevalent CRC patients aged 65 and older fro…
No prominent works on this page.
Comparison of Approaches for Estimating Prevalence Costs of Care for Cancer Patients
BACKGROUND: National prevalence costs of medical care can be key inputs in health policy decisions. Cost estimates vary across data sources, patient populations, and methods, however, the objective of this study was to compare 3 approaches for estimating the prevalence costs of colorectal cancer (CRC) care using different data sources, but similar patient populations and methods. METHODS: We identified prevalent CRC patients aged 65 and older fro…
Jama Health Forum Peer Reviewers in 2021
Jama Health Forum Peer Reviewers in 2022
Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
In this cross-sectional study of 18 top-selling brand-name drugs, excluding 1 anomaly, Medicaid average net prices declined from 2015 to 2019. Simultaneously, for non-Medicaid payers, net price increased more than previously published marketwide growth rates, raising the importance of restraining drug price growth in non-Medicaid markets. Rigorous and transparent methods to estimate Medicaid discounts are imperative to understand patterns in Medi…
Medicine (4 works) · Computer Science (2 works) · Health and Medical Research Impacts (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Law (2 works) · Law (2 works) · Library science (2 works) · Peer review (2 works) · Political science (2 works)